Monthly Cost Breakdown: Wegovy vs Mounjaro Pricing
How Much Is Wegovy Per Month vs Mounjaro: Complete Cost Analysis
Understanding how much Wegovy costs per month compared to Mounjaro requires examining both medications' dose escalation schedules. Wegovy follows a 5-dose progression over 16 weeks, starting at £79.99 for the 0.25mg dose and reaching £209.99 monthly for the 2.4mg maintenance dose. Mounjaro uses a 6-dose escalation from 2.5mg to 15mg, with its own pricing structure that reflects tirzepatide's dual-hormone mechanism targeting both GLP-1 and GIP receptors.
The monthly cost comparison becomes clearest when examining maintenance dosing, where patients typically spend 6-12 months or longer. Wegovy's maintenance dose of 2.4mg costs £209.99 per month, while Mounjaro's maintenance doses vary between £189.99 and £239.99 depending on the individual's optimal dose. Both medications require prescription-only access through clinical assessment, ensuring appropriate patient selection and ongoing monitoring throughout treatment.
Wegovy Monthly Pricing: From Starter to Maintenance
Calculating how much Wegovy costs per month starts with understanding the mandatory dose escalation protocol approved by the MHRA. The starter dose of 0.25mg costs £79.99 monthly (weeks 1-4), progressing to 0.5mg at £94.99 (weeks 5-8), then 1mg at £99.99 (weeks 9-12), and 1.7mg at £139.99 (weeks 13-16). The maintenance dose of 2.4mg reaches £209.99 per month from week 17 onwards, representing the long-term monthly investment for continued weight management support.
EverydayMeds offers bundle packages that can provide supply convenience without requiring monthly orders. The Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, while Getting Started bundles like the Intro Duo combine your first two doses (0.25mg and 0.5mg) for £169.99. New customers can apply discount code FIRST40 at checkout, while returning patients use code DOSE25 to access these competitive pricing levels.
Clinical Evidence: STEP Trials vs SURMOUNT Studies
When evaluating how much Wegovy costs per month, the clinical evidence from STEP trials provides important context for value assessment. In STEP 1, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP programme demonstrated consistent results across different patient populations, including those with type 2 diabetes.
Mounjaro's SURMOUNT trials showed its own efficacy profile, though direct comparison between trials isn't appropriate due to different study designs and patient populations. Both medications require commitment to reduced-calorie diet and increased physical activity as part of comprehensive weight management. The monthly investment in either treatment should be viewed alongside the broader health and lifestyle changes required for optimal outcomes.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone produced in your intestines after eating. This mechanism helps reduce appetite by acting on brain appetite centres, while also promoting feelings of fullness after smaller meals and potentially reducing food cravings. The once-weekly FlexTouch pen delivers consistent medication levels, supporting sustained appetite regulation throughout the week. Unlike Mounjaro's dual GLP-1 and GIP receptor targeting, Wegovy focuses specifically on GLP-1 pathways that have been extensively studied in weight management. The medication works alongside dietary changes and increased physical activity, not as a standalone solution for weight management.
Ordering Process: From Assessment to Delivery
Accessing Wegovy or Mounjaro through EverydayMeds begins with a 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review each application within standard 3 working days, or 24 hours with express service, ensuring appropriate patient selection for these prescription-only medicines. Once approved, your medication ships via next-day delivery using cold-chain temperature-controlled logistics to maintain product integrity. The process includes ongoing support for dose escalation timing and any questions about administration technique. All patients receive comprehensive information about proper injection technique, storage requirements, and what to expect during the initial weeks of treatment.
Storage and Practical Considerations
Both Wegovy and Mounjaro require refrigerated storage at 2-8°C before first use, but their room temperature stability differs significantly. Wegovy can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, while Mounjaro allows only 21 days at room temperature. This storage advantage makes Wegovy more convenient for travel or situations where refrigeration isn't immediately available. The FlexTouch pen design provides precise dose delivery with each weekly injection, and the dose escalation schedule cannot be accelerated regardless of individual tolerance. Both medications must be administered alongside lifestyle modifications including reduced-calorie diet and increased physical activity for optimal effectiveness.
Comparing Monthly Costs: Wegovy vs Mounjaro Investment
The question of how much Wegovy costs per month becomes more nuanced when compared directly with Mounjaro's pricing structure. Wegovy's 5-dose escalation spans 16 weeks with clearly defined monthly costs, while Mounjaro's 6-dose progression may require different timing based on individual tolerance and response. Both medications represent significant monthly investments, particularly at maintenance dosing where patients typically remain for extended periods.
EverydayMeds stocks both medications, allowing patients and prescribers to choose based on clinical appropriateness rather than availability constraints. The monthly cost calculation should include not just the medication price, but also the comprehensive support provided through our GPhC-registered pharmacy service. This includes clinical assessment, prescriber review, temperature-controlled delivery, and ongoing patient support throughout treatment.
Making Your Choice: Wegovy vs Mounjaro Decision Factors
Beyond monthly pricing, several factors influence the choice between Wegovy and Mounjaro for weight management. Wegovy's semaglutide targets GLP-1 receptors exclusively, while Mounjaro's tirzepatide acts on both GLP-1 and GIP receptors, potentially offering different therapeutic approaches. The storage requirements, dose escalation schedules, and individual patient response patterns all contribute to the decision-making process. Your prescriber will consider your medical history, current medications, weight management goals, and practical lifestyle factors when recommending the most appropriate option. Both treatments are available through EverydayMeds with the same high standards of pharmaceutical care, clinical oversight, and delivery service, ensuring you receive comprehensive support regardless of which medication proves most suitable for your individual circumstances.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
